Meeting
2024 ASCO Genitourinary Cancers Symposium
Real world evidence from a retrospective multi-center analysis on first-line therapy for metastatic renal cell carcinoma with non-clear cell and/or sarcomatoid histologies.
Authors
Pia Paffenholz
Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, University of Cologne Faculty of Medicine and University Hospital Cologne, Cologne, Germany
Pia Paffenholz , Stefanie Zschaebitz , Jozefina Casuscelli , Emily Rinderknecht , Angelika Mattigk , Melis Gür , Philipp Ivanyi , Thomas Hilser , Christopher Darr , Subhajit Mandal , Katrin Schlack , Daniel Seidl , Analena Handke , Melanie Klee , Tim Nestler , Marc Rehlinghaus , Sameh Hijazi , Axel Heidenreich , Viktor Grünwald , Martin Schostak
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer
Sub Track
Quality of Care/Quality Improvement and Real-World Evidence
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 392)
DOI
10.1200/JCO.2024.42.4_suppl.392
Abstract #
392
Poster Bd #
F16
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Real world outcomes of patients with non-clear cell renal cell carcinoma: A single Asian centre experience.
First Author: Johan W.K. Chan
Poster
2017 Genitourinary Cancers Symposium
Analysis of predictive clinical markers of outcome in patients with metastatic clear-cell renal cell carcinoma (mRCC) treated with tyrosine-kinases inhibitors (TKI) in first line: A C Camargo Cancer Center experience.
First Author: Camila Nassif Martins Ferreira
Poster
2014 Genitourinary Cancers Symposium
Patients with metastatic papillary renal cell carcinoma (RCC) who may benefit from sunitinib therapy (tx): Results from an international metastatic RCC database.
First Author: Daniel Kejzman
Poster
2014 Genitourinary Cancers Symposium
Liver metastases as predictors of outcome in renal cell carcinoma (RCC) patients (pts) treated with first-line sunitinib (SU) and sorafenib (SO).
First Author: Paolo Grassi